Furthermore, a recent meta-analysis of studies reporting PD-L1 expression by immunohistochemistry or PCR quantification, and PDA patient outcome, found that PDL-1 positivity/high expression was associated with significantly poorer survival (68). The gene discussed is CD274; the disease is Patent ductus arteriosus.